Creyos

Creyos Cambridge Brain Sciences is a leading web-based platform for the assessment of cognitive function, built for healthcare practitioners and researchers.

Find out more at cambridgebrainsciences.com. Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows researchers and healthcare providers to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Healthcare providers using C

reyos Health also have access to digital versions of many standardized patient health questionnaires.

πŸ“ At Becker's 16th Annual Meeting in Chicago, discussions about dementia care had moved from exploration to infrastructu...
06/02/2026

πŸ“ At Becker's 16th Annual Meeting in Chicago, discussions about dementia care had moved from exploration to infrastructure.

This year it wasn't about whether health systems should invest in cognitive health. It was about how to build programs, scale them across systems, and make the finances work. Speakers from major health systems described care models for dementia that mirror how those same systems already approach cancer care.

Catriona Galbraith, Creyos Strategic Accounts Director, recaps what stood out and what it means for cognitive health strategy:

https://hubs.li/Q04jRfW90

πŸ’¬ The right service, in the right place, at the right time.Our CEO Marc Lipton heard versions of that framing at industr...
05/27/2026

πŸ’¬ The right service, in the right place, at the right time.

Our CEO Marc Lipton heard versions of that framing at industry conferences and executive roundtables in the first half of this year, from payer executives, system CMOs, and primary care leaders.

For cognitive health, the gap between that aspiration and what happens in primary care today is measurable. And it's an infrastructure problem, not an awareness one.

Read Marc's reflection on the Creyos blog: https://hubs.ly/Q04j68j-0

One thing that’s become clear across brain health conversations this year:Earlier detection of cognitive decline only ma...
05/26/2026

One thing that’s become clear across brain health conversations this year:

Earlier detection of cognitive decline only matters if it’s practical to implement β€” especially in already strained healthcare environments.

✈️ This week at APG Spring in San Diego, Creyos Chief Marketing Officer Erin Smith will be connecting with healthcare leaders to discuss what scalable cognitive assessment actually looks like in practice β€” for clinicians, patients, and care systems alike.

We're looking forward to conversations around population health, value-based care, and the future of accessible cognitive assessment.

πŸ“ We're excited to return to the Millennium Alliance Healthcare Providers Transformation Assembly in Miami, June 2–3!Jam...
05/20/2026

πŸ“ We're excited to return to the Millennium Alliance Healthcare Providers Transformation Assembly in Miami, June 2–3!

Jamie Zuckier, Faraz Shafaghi, and Marc Lipton will be on-site and looking forward to connecting with Healthcare leaders from across the U.S.

🧠 Mild cognitive impairment is both common and surprisingly underdetected, particularly in primary care settings where f...
05/19/2026

🧠 Mild cognitive impairment is both common and surprisingly underdetected, particularly in primary care settings where formal cognitive testing often isn't part of the workflow at all.

In a new NeurologyLive interview, Creyos Chief Scientific Officer Adrian Owen, PhD, OBE, discusses the research behind the Creyos Dementia Screener.

Built using machine learning, the screener is designed to flag early signs of cognitive decline in minutes, without requiring specialist training to administer.

Read the full interview: https://hubs.li/Q04hb7P40

🧠 The AAN Annual Meeting covered a lot of ground. Alzheimer's biomarkers, cognitive care in neurodiverse populations, me...
05/15/2026

🧠 The AAN Annual Meeting covered a lot of ground. Alzheimer's biomarkers, cognitive care in neurodiverse populations, menopausal brain fog, medication-related impairment.

For our team, one theme stood out across all of it: whether cognitive measurement is keeping pace with what the field needs from it.

Creyos Staff Scientist Sydni Paleczny shares her reflections from the meeting.

πŸ” Read her full recap on the Creyos blog: https://hubs.li/Q04gNH4K0

🧠 Creyos cognitive tasks provide objective measures of different areas of cognition.The four domains measured:🟦 Short-te...
05/14/2026

🧠 Creyos cognitive tasks provide objective measures of different areas of cognition.

The four domains measured:
🟦 Short-term memory
🟩 Reasoning
🟨 Concentration
πŸŸͺ Verbal ability

Each task gathers domain-specific data in minutes, either remotely or in person. Used alongside behavioral health questionnaires within the platform, they give clinicians a fuller picture of a patient's neuropsychological symptoms.

This article on the Creyos blog walks through each task, what it measures, and the clinical context behind it: https://hubs.li/Q04gHSGh0

🧠 98% of neurologists now use telehealth in some capacity.From telestroke consults to multiple sclerosis monitoring to e...
05/08/2026

🧠 98% of neurologists now use telehealth in some capacity.

From telestroke consults to multiple sclerosis monitoring to epilepsy management, virtual visits are reshaping how neurologists deliver care. The bigger question is how practices are adapting their diagnostic workflows to keep up.

This article covers where telemedicine is proving most effective in neurology, and how practices are streamlining everything from follow-ups to cognitive assessment.

Read more: https://hubs.li/Q04fYZ7V0

πŸ“ AMGA's Annual Conference drew more than 1,300 attendees this year. If the sessions were any indication, healthcare's r...
05/05/2026

πŸ“ AMGA's Annual Conference drew more than 1,300 attendees this year. If the sessions were any indication, healthcare's relationship with AI has shifted meaningfully in 12 months.

Last year, the conversation centered on efficiency: scheduling, documentation, workflow. This year, it moved to scope and ex*****on. The question isn't "should we" anymore. It's "how do we?"

Creyos Chief Marketing Officer Erin Smith shares her reflections on that shift, the hard realities of value-based care, and the brain health work that's gaining traction across the AMGA community.

Read her full recap: https://hubs.li/Q04fyQ5z0

πŸ—“οΈ The 2026 telehealth billing landscape is now in effect.Between a new CPT code family, a congressional extension throu...
05/01/2026

πŸ—“οΈ The 2026 telehealth billing landscape is now in effect.

Between a new CPT code family, a congressional extension through 2027, and Medicare's decision not to reimburse most of the new codes, many practices are navigating a dual-track coding environment.

Our latest article walks through what changed, where Medicare and commercial payers diverge, and where the risk of denial now sits.

Read more: https://hubs.li/Q04f5tCT0

Address

214 King Street W. Suite 210
Toronto, ON
M5H3S6

Alerts

Be the first to know and let us send you an email when Creyos posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Creyos:

Share